A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy

Leukemia Research

Volumn 26, Issue 6, 2002, Pages 601-606

  Hauswirth, Alexander W ^a   Sperr, Wolfgang R ^a   Ghannadan, Minoo ^a   Schernthaner, Gerit Holger ^a   Jordan, John Hendrik ^a   Fritsche Polanz, Robert ^a   Simonitsch Klupp, Ingrid ^a   Födinger, Manuela ^a   Lechner, Klaus ^a   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Classification; Disease criteria; Mastocytosis; Prognosis

Indexed keywords

STEM CELL FACTOR;

ADULT; ARTICLE; ASSOCIATED HEMATOLOGIC CLONAL NON MAST CELL LINEAGE DISEASE; BONE MARROW; CASE REPORT; CELL AGGREGATION; CLINICAL FEATURE; DISEASE COURSE; EOSINOPHILIA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; LEUKOCYTOSIS; LYMPHADENOPATHY; MAST CELL; MUTATION; PRIORITY JOURNAL; SKIN DEFECT; SPLENOMEGALY; SYSTEMIC MASTOCYTOSIS;

ADULT; BONE MARROW; DNA MUTATIONAL ANALYSIS; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHATIC DISEASES; MASTOCYTOSIS; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0036252870     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00172-2     Document Type: Article

References (29)

1. Mast cells and mast cell neoplasia: A review
2. Tissue mast cells in health and disease
3. Classification and diagnosis of mastocytosis: Current status
4. Biology, classification and treatment of human mastocytosis
5. The natural course of urticaria pigmentosa
6. Systemic mast cell disease: Analysis of 58 cases and literature review
7. Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital
8. Analysis of the surface expression of C-KIT and occurrence of the C-KIT Asp-816-Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
9. Activating and dominant inactivating C-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
10. Somatic C-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
11. Identification of a point mutation in the catalytic domain of the protooncogene C-KIT in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
12. Bone marrow findings in systemic mastocytosis
13. Diagnostic value of immunostaining for tryptase in patients with mastocytosis
14. Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings
15. Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis
16. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
17. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
18. Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
19. Mast cell leukemia: Report of a case and review of the literature
20. Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis
21. Significance of systemic mast cell disease with associated hematologic disorders
22. Blood findings in generalized mastocytosis: Evidence of frequent simultaneous occurrence of myeloproliferative disorders
23. Clinical and biologic diversity of leukemias occuring in patients with mastocytosis
24. Diagnostic criteria and classification of mastocytosis: A consensus proposal
25. Detection of C-KIT mutation Asp-816-Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia
26. Slowly progressive systemic mastocytosis with high mast cell burden and no evidence of a non-mast cell hematolopic disorder: An example of a smouldering case?
27. A case of smouldering mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val
28. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis
29. Human proto-oncogene C-KIT: A new cell surface receptor tyrosine kinase for an unidentified ligand